Form 4 for SABS SAB Biotherapeutics, Inc.
Accepted 2021-10-05 00:00:00 ET · period of report 2021-10-01 · accession 0001493152-21-024641 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-10-05 | 2021-10-01 | SABS | Spragens Jeffrey G | Dir | P - Purchase | $10.07 | +13.0K | 13.0K | New | +$130.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-01 | P | A | 13,000 | $10.07 | 13,000 | D | — | — |